[DOI] [PMC free article] [PubMed] [Google Scholar] 711.Tay J, Thompson CH, Luscombe-Marsh ND, et al
The long-term safety profile is generally reassuring
This delay shows why drinking water regularly is important
The exact BMI thresholds the FDA sets for GLP-1 medications The FDA approval language is remarkably consistent across GLP-1 medications approved for weight management
Discovery Semaglutide, developed by Novo Nordisk and marketed under the brand name Ozempic, is a glucagon-like peptide-1 (GLP-1) analogue
Dosage goes up incrementally: 0.25mg Starter dose taken once weekly for the first 4 weeks to help your body adjust and reduce the risk of side effects 0.5mg Second step dose, usually taken for 4 weeks, allowing your body to continue adapting 1mg Mid escalation dose that begins to deliver stronger appetite suppression 1.7mg Higher step up dose used before reaching maintenance, supporting increased effectiveness 2.4mg Typical maintenance dose for long-term weight management and maximum clinical benefit In the first few weeks, many people feel full sooner during meals and are less tempted by large portions or late-night snacks
